The estimated Net Worth of Tao Levy is at least $4.71 Milione dollars as of 6 December 2021. Mr. Levy owns over 3,000 units of Masimo Corp stock worth over $1,323,805 and over the last 7 years he sold MASI stock worth over $826,410. In addition, he makes $2,557,310 as Executive Vice President - Business Development at Masimo Corp.
Tao has made over 1 trades of the Masimo Corp stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of MASI stock worth $826,410 on 6 December 2021.
The largest trade he's ever made was selling 3,000 units of Masimo Corp stock on 6 December 2021 worth over $826,410. On average, Tao trades about 300 units every 0 days since 2018. As of 6 December 2021 he still owns at least 11,593 units of Masimo Corp stock.
You can see the complete history of Mr. Levy stock trades at the bottom of the page.
Tao Levy serves as Executive Vice President - Business Development of the Company. From March 2013 to December 2017, Mr. Levy served as Managing Director, Medical Devices Equity Research, at Wedbush Securities. Prior to that time, he served as Senior Analyst, Medical Devices Equity Research at Loewen Ondaatje McCutcheon, from August 2012 to March 2013. From September 2010 to February 2012, Mr. Levy was Managing Director, Medical Devices Equity Research at Collins Stewart. Prior to his time at Collins Stewart, Mr. Levy was Director, Medical Devices Equity Research at Deutsche Bank where he served from 2002 to 2010. He holds a Bachelor of Arts in Biology from the University of Pennsylvania.
As the Executive Vice President - Business Development of Masimo Corp, the total compensation of Tao Levy at Masimo Corp is $2,557,310. There are 3 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.
Tao Levy is 46, he's been the Executive Vice President - Business Development of Masimo Corp since 2018. There are 20 older and 5 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.
Tao's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill e Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Masimo Corp executives and other stock owners filed with the SEC include: